| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |